Chromogranin A as a valid marker in oncology: Clinical application or false hopes?

doi:10.5662/wjm.v7.i1.9

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 7, Issue 1

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (11196)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Tables (1-3) series.

Item

Count

PDF

705

WORD

468

HTML

7324

Tables (1-3)

199

Sum=8696

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1257

Download

1243

Sum=2500

Mar 26, 2017 (publication date) through Jul 27, 2024

Times Cited of This Article

Times Cited (35)

Journal Information of This Article

Publication Name

World Journal of Methodology

ISSN

2222-0682

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Methodol. Mar 26, 2017; 7(1): 9-15
Published online Mar 26, 2017. doi: 10.5662/wjm.v7.i1.9

Table 2 Frequent cancer-related causes of increased chromogranin A

Cancer	Neuroendocrine tumors
Breast	Colorectal
Colon	Gastric
Hepatocellular	Medullary thyroid
Ovarian	Neuroblastoma
Pancreatic	Pancreatic
Prostate	Paraganglioma
	Pheochromocytoma
	Pituitary
	Small cell lung
	Small intestinal

Citation: Gkolfinopoulos S, Tsapakidis K, Papadimitriou K, Papamichael D, Kountourakis P. Chromogranin A as a valid marker in oncology: Clinical application or false hopes? World J Methodol 2017; 7(1): 9-15
URL: https://www.wjgnet.com/2222-0682/full/v7/i1/9.htm
DOI: https://dx.doi.org/10.5662/wjm.v7.i1.9